Global Methicillin-resistant Staphylococcus Aureus Market: Increased Research and Development Activities Key Opportunity for Growth

Published Date : Aug 01, 2016

ALBANY, NY, Aug 01, 2016A new market research study, titled “Methicillin-Resistant Staphylococcus Aureus (MRSA) - Current and Future Players,” has been added to the huge repository of research reports on The 125-page research study offers an in-depth reports of the market, presenting insights into the key growth drivers, barriers, and potential opportunities. The research study throws light on the competitive scenario of the global methicillin-resistant staphylococcus aureus market and offers a detailed reports of the key players engaged in the market.

The research study offers information about the past and present performance of the leading companies engaged in the global MRSA market. The report classifies and analyzes the prominent companies that are projected to influence the growth of the global MRSA market throughout the forecast period. In addition, the research study provides a detailed reports of the players expected to enter the global MRSA market in the next few years.

Methicillin-resistant staphylococcus aureus is a skin infection occurring mostly in healthcare facilities and hospitals. MRSA is considered as extremely contagious and is treated with antibiotics. At times, this infection is difficult to treat, as it is resistant to some of the commonly used antibiotics, including methicillin. The increasing prevalence of early detection of this infection is projected to boost the demand for MRSA drugs and therapeutics in the next few years.

According to the research study, the elderly are extremely prone to MRSA, particularly in hospital environments, due to their weakened immune system. The rise in the prevalence of infections and various diseases is one of the prominent factors propelling the global MRSA market. The growing awareness regarding the treatments and availability of drugs is expected to drive the overall market in the forecast period. Government-based and private institutions are taking initiatives to develop new antibiotics by allotting the required funds for research and development activities. Such funding is encouraging the key players to invest in antibiotic research, contributing extensively towards the growth of the market.

For Sample Copy, click here:

The key players in the methicillin-resistant staphylococcus aureus market are actively engaged in research and development activities, as there is a high demand for effective treatment options for MRSA across the globe. The market players are focusing on the introduction of new drugs and therapeutics with high efficiency and safety profiles in order to gain a competitive advantage in the overall market. The promising pipeline products of the leading companies are expected to fuel the growth of the market in the coming few years.

The leading players operating in the global MRSA market include Theravance Biopharma, Basilea Pharmaceutica, Merck, Allergan, The Medicines Company, Sanofi, and Pfizer. Some of the other prominent players mentioned in the research study are Debiopharm International, Nabriva Therapeutics, Kyorin Pharmaceutical, Melinta Therapeutics, Cempra Pharmaceuticals, Cellceutix Corporation, and Paratek Pharmaceuticals. The profiles, pipeline products, marketing strategies, financial status, SWOT reports, and recent developments of these companies have been discussed in the research report.

To order report Call Toll Free: 866-997-4948 or send an email on